4 trends tracked about this subject — the full history, oldest to newest below.
A failed Novartis cholesterol drug trial has triggered a biopharma selloff, casting doubt on the multibillion-dollar race to target Lp(a).
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Anthropic is aggressively entering the biopharma sector through a 100-day sprint involving Nobel laureates, M&A activity, and new scientific AI tools.
The FDA has launched the PreCheck pilot program with seven participants to accelerate and strengthen the domestic manufacturing of drugs in the United States.